Michael J. Higgins - 01 Jul 2021 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC. (GNCA)

Role
Director
Signature
/s/ Diantha Duvall, Attorney-in-Fact
Issuer symbol
GNCA
Transactions as of
01 Jul 2021
Transactions value $
$0
Form type
4
Filing time
02 Jul 2021, 11:49:05 UTC
Previous filing
04 Jun 2021
Next filing
18 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GNCA Stock Option (Right to Buy) Award $0 +15K $0.00 15K 01 Jul 2021 Common Stock 15K $2.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the options are scheduled to vest on the first anniversary of the grant date.